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Abstract Ensifer meliloti is a nitrogen-fixing sym-
biont of the alfalfa legume able to use heme as an iron
source. The transport mechanism involved in heme
acquisition in E. meliloti has been identified and
characterized, but the fate of heme once inside the cell
is not known. In silico analysis of E. meliloti 1021
genome revealed no canonical heme oxygenases
although two genes encoding putative heme degrading
enzymes, smc01518 and hmuS, were identified.
SMc01518 is similar to HmuQ of Bradyrhizobium
japonicum,which is weakly homologous to the Staphy-
lococcus aureus IsdG heme-degrading monooxyge-
nase, whereas HmuS is homolog to Pseudomonas
aeruginosa PhuS, a protein reported as a heme chaper-
one and as a heme degrading enzyme. Recombinant
HmuQ and HmuS were able to bind hemin with a 1:1
stoichiometry and displayed a Kd value of 5 and 4 lM,
respectively. HmuS degrades heme in vitro to the
biliverdin isomers IX-b and IX-d in an equimolar ratio.
The HmuQ recombinant protein degrades heme to
biliverdin IX-d only. Additionally, in this work we
demonstrate that humS and hmuQ gene expression is
regulated by iron and heme in a RirA dependent manner
and that both proteins are involved in heme metabolism
in E. meliloti in vivo.
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Introduction
Ensifer meliloti belongs to the group of rhizobia,
whose most conspicuous characteristic is the ability to
establish symbiotic association with legumes and
carry out nitrogen fixation. Rhizobia are normally
present in different habitats (e.g. soil, rhizosphere,
plant host) where free iron is usually mostly inacces-
sible due to low solubility, organic binding or
immobilization. E. meliloti and many other bacteria
possess different high affinity iron acquisition systems
that share common traits: are maximally expressed
when iron is scarce and, involve the presence of TonB-
dependent outer membrane receptors and ABC trans-
porters (O’Brian and Fabiano 2010). In E. meliloti
strain 1021, these systems include the production and
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secretion of the rhizobactin 1021 siderophore, the
hijacking of xenosiderophores (ferrichrome and fer-
rioxamine B) and the acquisition of iron from heme
compounds (Cuiv et al. 2008; Noya et al. 1997;
Persmark et al. 1993). For many years, transport and
degradation of heme as a mechanism to acquire iron
was thought to be exclusive to pathogens. However,
our group discovered that rhizobia and other non-
pathogenic bacteria can use heme or hemoglobin as
iron sources (Noya et al. 1997). Subsequently, genes
involved in heme transport were identified in
Bradyrhizobium japonicum, Rhizobium legumi-
nosarum and E. meliloti (Amarelle et al. 2008;
Battistoni et al. 2002; Nienaber et al. 2001; Wexler
et al. 2001). Notably, while the use of xenosider-
ophores was found to be a variable trait, heme
transport systems are present in all the rhizobia strains
studied so far. Moreover, rhizobia heme transport
systems are present in the chromosome and not in
plasmids, suggesting its importance for the metabo-
lism of these bacteria (O’Brian and Fabiano 2010).
The outer membrane heme-receptor involved in the
internalization of heme, hemoglobin and leghe-
moglobin in E. meliloti is ShmR (Amarelle et al.
2008; Battistoni et al. 2002) and HmuTUV is the ABC
transporter required, among other functions, for heme
uptake (Cuiv et al. 2008). Expression of the E. meliloti
shmR gene under iron limitation involves the loss of
the repression exerted by RirA (Rhizobial iron regu-
lator) (Chao et al. 2005; Viguier et al. 2005) as well as
the activation mediated by the HmuP protein (Amar-
elle et al. 2010). RirA is the primary iron-responsive
transcriptional regulator in E. meliloti, while the Fur
homolog, renamed as Mur, is mainly involved in the
control of manganese homeostasis (Chao et al. 2005;
Diaz-Mireles et al. 2004; Platero et al. 2004). The fate
of exogenous heme once inside E. meliloti cytosol is
unknown.
Different enzymes and mechanisms allowing iron
release from heme have been described in bacteria
(Benson and Rivera 2013; Wilks and Ikeda-Saito
2014). In Corynebacterium diphtheria, the pioneering
work of Schmitt (1997) and Wilks and Schmitt (1998)
demonstrated that once heme is taken up by bacterial
cell, the tetrapyrrole ring is cleaved by heme oxyge-
nases (HOs) in order to release iron. HOs are
ubiquitous enzymes that degrade heme to biliverdin
IX-a, iron and carbon monoxide, using O2 and a
reductant such as NADPH cytochrome P450 reductase
for oxidation (Benson and Rivera 2013; Montellano
2000). Bacterial heme oxygenases have limited
sequence similarity to each other but are structurally
and mechanistically similar to those of the eukaryotic
HO (Hirotsu et al. 2004; Schuller et al. 1999, 2001;
Wilks and Ikeda-Saito 2014).
A novel class of heme-degrading enzyme, IsdG
(Iron-regulated surface determinant) structurally unre-
lated to canonical HOs, was discovered in Staphylo-
coccus aureus (Reniere et al. 2010; Skaar et al. 2004;
Wu et al. 2005). Homologous to this heme-degrading
enzyme, which belongs to the group of the antibiotic
biosynthesis monooxygenase family (ABM), were
also found in a limited number of gram-positive and
gram-negative bacteria (Ojeda et al. 2012; Park et al.
2014; Puri and O’Brian 2006; Skaar et al. 2006).
Interestingly, some members of this group of enzymes
such as IsdG and IsdI of S. aureus and HmoB of
Bacillus subtilis, catalize the degradation of heme to
staphylobilins (15-oxo bilirubin IX-b and 5-oxo-
bilirubin IX-d) and formaldehyde rather than to
biliverdin and CO (Matsui et al. 2013; Park et al.
2014; Reniere et al. 2010). In Mycobacterium tuber-
culosis, the IsdG homolog named MhuD, catalyzes
heme degradation producing a novel heme catabolite,
mycobilin, without the release of CO or formaldehyde,
and retaining the meso-carbon of the porphyrin ring as
an aldehyde (Nambu et al. 2013). In B. japonicum, two
heme-degrading enzymes belonging to the ABM
group of enzymes, HmuQ and HmuD, have been
described. HmuQ has weak homology with S. aureus
IsdG, being biliverdin the heme degradation product
(Puri and O’Brian 2006).
The hemS (or hmuS) gene is annotated as a ‘‘heme
degrading enzyme’’ in the genome databases although
this activity has been demonstrated only for few
bacteria. Particularly, this activity has been reported
for ChuS in Escherichia coli and PhuS in Pseu-
domonas aeruginosa (Lee et al. 2014; Suits et al.
2005). The crystal structure of ChuS from E. coli
O157:H7 has been characterized and presents a
different folding structure than that of known mam-
malian and bacterial HOs (Suits et al. 2005). Addi-
tionally, iron release from heme without tetrapyrrole
ring disruption was found in E. coli (Letoffe et al.
2009; Turlin et al. 2014).
HO function has been associated with cellular
signaling, antioxidant defense and biosynthesis of
light-sensing bilins. HO also participates in the use of
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heme as nutritional iron source in numerous bacteria
(Benson and Rivera 2013; Frankenberg-Dinkel 2004).
Here we report the identification and characteriza-
tion of two enzymes from E. meliloti 1021 with heme
degrading activity in vitro: HmuQ and HmuS. We
demonstrate that both proteins bind heme, are capable
of degrading this compound and produce biliverdin.
Moreover we demonstrate that humQ and hmuS gene
expression is regulated by iron and heme, and that both
proteins are involved in heme metabolism in E.
meliloti in vivo.
Materials and methods
Bacteria, plasmids and growth conditions
Bacteria and plasmids used in this study are listed in
Table 1. E. coli strains were grown aerobically at 37 C
in Luria–Bertani (LB) medium or 2xYT medium
(Sambrook et al. 1989). E. meliloti strains were grown
at 30 C in tryptone-yeast extract medium (TY)
(Beringer 1974), defined minimal medium M9 (Sam-
brook et al. 1989) supplemented with 6 mM glutamate,
200 lM methionine and 1 lM biotin (M9S) or LB
medium supplemented with 2.5 mM MgSO4 and
2.5 mM CaCl2 (LBMC). Low iron conditions were
obtained by supplementation with ethylenediamine-di-
o-hydroxyphenylacetic acid (EDDHA) and high iron
conditions were obtained by adding FeCl3 to the media.
The micromolar concentrations of FeCl3, EDDHA
(abbreviated as E) and hemin (Hm) used for each assay
are indicated with subscripts When required, 50 lg/ml
kanamycin (Km), 100 lg/ml neomycin (Nm), 100 lg/
ml streptomycin (Sm), 10 lg/ml gentamycin (Gm) (for
E. coli), 5 lg/ml gentamycin (for E. meliloti), 50 lg/ml
ampicillin (Ap) or 25 lg/ml cloramphenicol (Cm)were
added to the media.
Construction of Sm1021-VAQ and Sm1021-VAS
mutants
To generate an hmuQ mutant (Sm1021-VAQ), a
2350 bp DNA fragment containing the hmuQ gene
and flanking regions was amplified from E. meliloti
1021 genome using primers 5´-CGTAACCCCAAAAC-
GAACCTGTCC-3´ and 5´-CACCGTGGAAGTGTCGC
TGCT-3´. The fragment obtainedwas digestedwith PstI/
XhoI and cloned in pBlueScriptSK (pSK) (Stratagene)
obtaining plasmid pSKhmuQ. To interrupt the hmuQ
gene, the lacZ-Gmr cassette of pAB2001 (Becker et al.
1995) was cloned in the EcoRI site of pSKhmuQ
generatingpSKhmuQ::lacZ-Gmr.Cloning in the correct
orientation was confirmed by restriction mapping. The
hmuQ::lacZ-Gmr fragment was sub-cloned in the
BamHI site of pK18mobSacB (pK18) (Schafer et al.
1994) obtaining plasmid pK18hmuQ::lacZ-Gmr which
was then mobilized into E. meliloti 1021 by triparental
mating using DH5a-pRK2013 (Figurski and Helinski
1979) as a helper strain. Colonies Smr, Gmr and able to
grow in 15 % (w/v) sucrose (Sucr) were selected and the
mutationwas confirmed by Southern blot hybridization.
To obtain an hmuS mutant (Sm1021-VAS), a
2054 bp DNA fragment containing the hmuS gene
and flanking regions was amplified from E. meliloti
1021 genome using primers 5´-ATAGGATCCACGA
AGGTCAACTTGCA-3´ and 5´-TCTGGATCCAAGG-
GAATGTTCGCCTC-3´. BamHI restrictions sites are
underlined. The amplicon was cloned at the EcoRV
site of pSK obtaining plasmid pSKhmuS. An in-frame
deletion of hmuS gene was done by inverse PCR using
primers 5´-ATAGATATCGGTGGGGCGAATGCT-3´
and 5´-ATAGATATCGTCGCGGCCTGATGGTG-3´
and pSKhmuS as template. EcoRV restriction sites
are underlined. PCR product was digested with
EcoRV and autoligated in order to obtain plasmid
pSKhmuSif. The hmuS deleted gene was cloned in the
BamHI site of pK18 in order to generate plasmid
pK18hmuSif which was then mobilized into E. meliloti
1021 and Sm1021-VAQ strains by triparental mating
as previously described, in order to generate Sm1021-
VAS mutant and Sm1021-VAQS double mutant,
respectively. Smr and Sucr colonies were selected
and the mutations were confirmed by PCR.
In order to have the hmuQ and hmuS genes mutated
in a background where no endogenous siderophore is
produced, mutation in the rhrA gene of strain Sm1021-
H38 (Platero et al. 2003) was transduced with phage
AM12 (Finan et al. 1984) to the Sm1021-VAQ,
Sm1021-VAS and Sm1021-VAQS mutant strains.
Transductions were done as previously described
(Finan et al. 1984). Briefly, AM12 lysates of
Sm1021-H38 mutant were generated by growing
Sm1021-H38 in LBMC, culture diluted to an OD600nm
of 0.3–0.4 in LBMC was incubated with AM12 at
30 C until complete lysis occur. Lysates were filtered
and diluted in order to infect Sm1021-VAQ, Sm1021-
VAS and Sm1021-VAQS cells previously grown in
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Table 1 Bacterial strains and plasmids used in this work
Strain or plasmid Relevant characteristics References
E. meliloti
Sm1021 Streptomycin derivative of wild-type strain SU47 (Smr) (Meade et al.
1982)
Sm1021-H38 Sm1021 rhrA::Tn5-1063a. Siderophore deficient strain (Nmr, Smr) (Platero et al.
2003)
Sm1021-VAQ Sm1021 hmuQ::lacZ-Gmr (Smr, Gmr) This work
Sm1021-VAS Sm1021 DhmuS (Smr) This work
Sm1021-VAQS Sm1021 hmuQ::lacZ-Gmr; DhmuS (Smr, Gmr) This work
Sm1021-H38VAQ Sm1021-H38 hmuQ::lacZ-Gmr (Nmr, Smr, Gmr) This work
Sm1021-H38VAS Sm1021-H38 DhmuS (Nmr, Smr) This work
Sm1021-H38VAQS Sm1021-H38 hmuQ::lacZ-Gmr; DhmuS (Nmr, Smr, Gmr) This work
Sm1021-TR2 Sm1021, DrirA (Smr) (Chao et al.
2005)
Sm1021-TR2VAQ Sm1021-TR2, hmuQ::lacZ-Gmr (Smr, Gmr) This work
Sm1021 (pOT) Sm1021 containing plasmid pOT1 (Smr, Gmr) (Platero et al.
2003)
Sm1021-TR2 (pOT) Sm1021-TR2 containing plasmid pOT1 (Smr, Gmr) This work
Sm1021 (pOT-
prhmuS)
Sm1021 containing plasmid pOT-prhmuS (Smr, Gmr) This work
Sm1021-TR2 (pOT-
prhmuS)
Sm1021-TR2 containing plasmid pOT-prhmuS (Smr, Gmr) This work
E. coli
DH5a supE44DlacU169(/80lacZDM15)hsdR17 recA1 endA1 gyrA96 thi-1 relA1 (Hanahan 1983)
BL21DE3(pLysS) F- ompT gal dcm hsdSB(rB
- mB
-) k(DE3) pLysS (Cmr) Novagen
Plasmids
pBlueScript SK Cloning vector (Apr) Startagene
pAB2001 Carrying lacZ-Gmr promoter-probe cassette (Gmr, Apr) (Becker et al.
1995)
pRK2013 ColE1 replicon with RK2 tra genes. Used for mobilizing incP and incQ plasmids (Kmr) (Ditta et al.
1980)
pK18mobSacB Broad host range mobilizable vector. Non replicative in E. meliloti, sacB, oriV (Kmr) (Schafer et al.
1994)
pSKhmuQ pBlueScript SK containing hmuQ coding sequence (Apr) This work
pSKhmuS pBlueScript SK containing hmuS coding sequence (Apr) This work
pSKhmuQ::lacZ-Gmr pBlueScript SK containing hmuQ coding sequence interrupted with lacZ-Gmr cassette
of pAB2001 (Apr, Gmr)
This work
pK18hmuQ::lacZ-
Gmr
pK18mobSacB containing hmuQ coding sequence interrupted with lacZ-Gmr cassette
of pAB2001 (Kmr, Gmr)
This work
pSKhmuSif pBlueScript SK containing hmuS coding sequence with an in-frame deletion (Apr) This work
pK18hmuSif pK18mobSacB containing hmuS coding sequence with an in-frame deletion (Kmr) This work
pSK-prhmuS pBlueScript SK containing the promoter region of hmuS (Apr) This work
pET14b IPTG-inducible expression vector with a 6 9 his tag at 50 end (Apr) Novagen
pET14b-HmuQ pET14b containing hmuQ coding sequence (Apr) This work
pET14b-HmuS pET14b containing hmuS coding sequence (Apr) This work
pOT1 Wide host range gfp-UV promoter-probe plasmid, derivative of pBBR1 (Gmr) (Allaway et al.
2001)
pOT-prhmuS pOT1 containing the promoter region of hmuS (Gmr) This work
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LBMC to an OD600nm of 0.8. Infection was carried on
for 20 min, cells were immediately washed twice with
TY and plated on TY supplemented with Sm and Nm.
Transductants were re-streaked twice in order to avoid
phage contamination.
With the aim to obtain the hmuQ gene mutated in a
background where the global iron regulator RirA is not
present, the hmuQ mutation of Sm1021-VAQ strain
was transduced with phage AM12 to the rirA mutant
strain. Transduction was performed as above-men-
tioned and Smr and Gmr colonies were selected.
Growth assays
For colony size experiments, appropriate dilutions of
mid-exponential (OD620nm of 0.8–1) cultures grown in
TY media were made. Dilutions were spotted with a
replica plater in TY solid medium, TY supplemented
with 150 lM EDDHA (TYE150) or TY supplemented
with 150 lM EDDHA and either 1 lM hemin
(TYE150Hm1), 10 lM hemin (TYE150Hm10) or
50 lM hemin (TYE150Hm50). Cells were grown
5 days at 30 C and colony sizes were recorded. For
growth experiments in liquid media, cells were grown
in M9S until mid-exponential phase (OD620nm of
0.8–1). 50-fold dilutions were done in M9S liquid
medium supplemented with 300 lM EDDHA,
300 lM EDDHA and different concentrations of
hemin, or 37 lM FeCl3. Cultures were incubated with
shaking at 30 C and growth was determined as
optical density at 600 nm using a Varioskan Flash
(Thermo).
Expression of hmuQ and hmuS genes
Three different approaches were performed:
i. RNA purification and real-time qPCR. Expression
of hmuQ and hmuS genes was assessed by quan-
titative real-time PCR (qPCR). For RNA isolation,
mid-exponential phase cultures of E. meliloti 1021
grown in M9S supplemented with 300 lM
EDDHA, 300 lM EDDHA and 1 lM Hm,
300 lM EDDHA and 20 lM Hm or 37 lM FeCl3
were used. RNA purification was performed as
described elsewhere (Amarelle et al. 2010). Rev-
erse transcription was carried out with total RNA
using the iScript cDNA Synthesis Kit (Bio-Rad).
Conditions used for real-time PCR were as
mentioned elsewhere (Amarelle et al. 2010).
Primers used for hmuQ quantification were 5´-TAC
TTCGCCATGAACCGTTTCCGT-3´ and 5´-CGC
AGCAGATGGAATTCGATGAAG-3´ and for
hmuS quantification were 5´-AATGGCGGCGT-
CATCCAGATTCAT-3´ and 5´-GCAGATGCA-
GATGGAAGGTTTCGT-3´. The generation of
specific PCR products was confirmed by melting
curve analysis. Gene smc03224, a 16S rDNA, was
used as a control using primers 5´-GTGTCTCAGT
CCCAATGT-3´ and 5´-TCTACGGAATAACG-
CAGG-3´ previously described (Dominguez-Fer-
reras et al. 2006). Reactions without reverse
transcriptase addition were used as negative con-
trols. For relative quantification, the standard curve
method was performed using E. meliloti 1021
genomic DNA as PCR template. The data are
expressed as the relative starting quantities (SQ) of
mRNA normalized to smc03224 and presented as
the average from three independent determinations.
ii. B-galactosidase transcriptional fusion. The tran-
scriptional fusion with the promoterless cassette
lacZ-Gmr, generated as a result of Sm1021-VAQ
mutant construction, was used also in the case of
hmuQ gene expression. b-galactosidase activity
was assessed in the Sm1021-VAQ mutant and in
rirA/hmuQ double mutant. E. meliloti 1021
parental strain and rirA mutant strain were used
as controls. Mid-exponential phase cultures
grown in M9S medium were diluted 100-fold in
M9S medium supplemented with either 37 lM
FeCl3, 300 lM EDDHA, 300 lM EDDHA plus
1 lM Hm or 300 lM EDDHA plus 20 lM Hm.
Mid-exponential phase cultures were used for b-
galactosidase assay, performed according to the
kinetic protocol described by Thibodeau et al.
(Thibodeau et al. 2004). Briefly, cells were lysed
with 1 % (v/v) triton X-100, 1 % (w/v) Sarkosyl
and 1 mg/ml of lysozyme for 15 min at room
temperature. An aliquot of 40 ll was transfer to a
Nunc F-bottom 96 well plate and 130 ll of Z
buffer (Miller 1972) with 0.27 % (v/v) b-mercap-
toethanol was added, and the plate was loaded in a
Varioskan Flash (Thermo) for substrate dispens-
ing. Plate was incubated 10 min at 30 C, 30 ll of
4 mg/ml o-Nitrophenyl b-D-galactopyranoside
(ONPG) in Z buffer was added to each well, and
the absorbance at 420 nm was recorded every
2 min over a period of one hour. The maximum
Biometals (2016) 29:333–347 337
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rate (DAbs/Dmin) was measured and the enzy-
matic activity, expressed as nmoles of o-Nitro-
phenol produced per min per optical density at
620 nm per ml, was determined. Each experiment
was performed independently three times.
iii. GFP-UV promoter fusion. In order to evaluate the
activity of the promoter region corresponding to
hmuS gene, a plasmid-borne transcriptional fusion
with gfp-UV was constructed. For this purpose, a
464 bp DNA fragment containing hmuPSTUV
promoter region was amplified from E. meliloti
1021 genome by PCR using primers 5´-
GGCCTTTCTGATCGAAGAGCACG-3´ and 5´-
CAGCGGCGCCACGGTTTG-3´. The amplicon
was cloned at the EcoRV site of pBSK generating
plasmid pSK-prhmuS. Correct orientation was
confirmed by restrictionmapping. AHindIII-XbaI
fragment was subcloned in plasmid pOT1 (All-
away et al. 2001) generating plasmid pOT-
prhmuS. Plasmid pOT-prhmuS and the pOT1
vector were mobilized into E. meliloti 1021
parental and rirA mutant strains by triparental
mating in order to generate Sm1021 (pOT-
prhmuS), Sm1021-TR2 (pOT-prhmuS) and
Sm1021-TR2 (pOT1) strains. Plasmid presence
in the Smr and Gmr obtained colonies was
confirmed by PCR. Previously constructed
Sm1021 (pOT1) (Platero et al. 2004) was used
as negative control. Cells were grown until mid-
exponential phase in M9S medium and diluted
100-fold in M9S medium supplemented with
either 300 lM EDDHA, 300 lM EDDHA plus
1 lM Hm, 300 lM EDDHA plus 20 lM Hm or
37 lM FeCl3. Expression of the green fluorescent
protein (GFP-UV) was evaluated in a Varioskan
Flash (Thermo) using a 405 nm excitation filter
and 505 nm emission filter. Quantitative relative
fluorescence (RF) was determined according the
method of Allaway et al. (Allaway et al. 2001)
expressed as fluorescence emission at 505 nm/
OD620nm. RF values calculated for hmuS promoter
fusions in E. meliloti 1021 parental and rirA
mutant strains were normalized to the RF values
obtained for control strains Sm1021 (pOT1) and
Sm1021-TR2 (pOT1) respectively. Results are the
mean of three replicates in the same experiment.
Each experiment was repeated independently
three times.
Cloning, overexpression and purification of HmuQ
and HmuS
Using pSKhmuQ or pSKhmuS plasmids as template,
hmuQ or hmuS open reading frames were amplified by
PCR. For hmuQ amplification, primers 5´-TCGGATC-
CATCTCAACAGGCCTGAG-3´ and 5´-GCAATTCA-
TATGTACTTCGCCATG-3´ were used. For hmuS
amplification, primers 50-GGGAATTCCATATGAC-
GATGACTGAG-30 and 50-CGCGGATCCGCCGTT-
CATCATCACTT-30 were used. Restriction sites
included in the primers are underlined. Products
obtained were cloned in the NdeI and BamHI sites of
pET14b (Novagen) generating plasmids pET14b-
HmuQ and pET14b-HmuS. E. coli BL21DE3(pLysS)
(Novagen) strain was transformed with each of these
plasmids. Overexpression and purification of HmuQ
and HmuS recombinant proteins was performed as
described by Friedman et al. (Friedman and O’Brian
2004). Correct overexpression and purification were
confirmed by SDS-PAGE. Fractions containing HmuQ
proteinwere equilibratedwith50 mMphosphate buffer,
pH 8.0, containing 300 mM NaCl and 10 % (v/v)
glycerol. Fractions containing HmuS protein were
equilibrated with 100 mM phosphate buffer, pH 8.0,
and 10 % (v/v) glycerol. Aliquots of 10 lM solution of
proteins were stored at-80 C for further use.
Heme binding and heme degradation assays
Heme binding and heme degradation assays were
performed as detailed elsewhere (Puri and O’Brian
2006). To determine the stoichiometry of heme
binding to HmuQ or HmuS, spectra were recorded
after each heme addition. Absorption at 413 nm was
plotted versus the heme concentration.
Heme degradation was determined spectrophoto-
metrically as the decrease in the heme absorbance in the
presence of the protein and either ascorbate or human
NADPH-cytochrome P450 reductase (Calbiochem) as
reductant. A heme degradation control without enzyme
in similar conditions was also performed.
338 Biometals (2016) 29:333–347
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Detection of biliverdin as HmuQ or HmuS reaction
products
Heme degradation reactions were made as mentioned
above. A mixture without HmuQ/HmuS protein was
used as a negative control to monitor heme degrada-
tion without enzymes (Hm control). Product extrac-
tion and HPLC–MS analysis were performed as
described by Puri et al. (Puri and O’Brian 2006).
Detection of dimethyl-esterified biliverdin isomers
as HmuQ or HmuS reaction products
Product extraction and esterification was performed as
described elsewhere (Wang et al. 2004). Dimethyl-
esterified HmuQ and HmuS products were dissolved
in CH2Cl2 and subsequently diluted in 0.1 % (v/v)
formic acid in acetonitrile, 1/2 and 1/20 respectively.
Samples were loaded in a C18 phenomenex luna
analytical HPLC column and a 1 ml/min flow of 0.1 %
(v/v) formic acid in acetonitrile was applied. The
gradient of acetonitrile (v/v) used was: 30 % acetoni-
trile 5 min, from 30 to 80 % 35 min, from 80 to 95 %
5 min, 95 % 5 min, from 95 to 30 % 5 min and
maintained at 30 % during 5 min.
Dimethyl-esterified biliverdin isomers of the IX
series, obtained as previously described (Bonnett and
McDonagh 1973), were suspended in 0.1 % (v/v)
formic acid in acetonitrile and used as a standards.
Results
In silico studies
We have previously shown that heme is used as an iron
source by E. meliloti 1021 and that the ShmR outer
membrane protein is required for heme transport
(Amarelle et al. 2008; Battistoni et al. 2002; Noya
et al. 1997). Here, we wanted to identify HO-encoding
genes in E. meliloti in order to evaluate their roles in
iron release from the tetrapyrrole ring. The analysis of
E. meliloti 1021 genome revealed no canonical HOs in
its genome, although two putative genes encoding
heme degrading enzymes, smc01518 and hmuS, were
identified. SMc01518 showed sequence similarity to
the ABM group of enzymes to which IsdG-family of
monooxygenases belong. The SMc01518 predicted
protein has 50 and 59 % sequence identity (SI) with B.
japonicum HmuD and HmuQ, respectively, and 35 %
SI with S. aureus IsdG with only 42 % of coverage.
Based on this homology and on data described below,
we renamed smc01518 as hmuQ.
The hmuS gene is annotated as a putative gene
encoding a hemin transport protein in the E. meliloti
genome. It is clustered together with genes involved in
heme, Ferrichrome and Ferrioxamine B transport
(hmuTUV) and in the regulation of shmR expression
(hmuP) (Fig. S1) (Amarelle et al. 2010; Cuiv et al.
2008). The HmuS amino acid predicted sequence has a
45 % SI with PhuS of P. aeruginosa and 37 % SI with
both ChuS of E. coli and HemS of Yersinia entero-
colitica. These orthologs of E. meliloti HmuS have
been reported to be involved in heme metabolism,
either acting as a heme-degrading enzyme or as a
heme chaperone and heme oxygenase titratable regu-
lator of heme uptake (Lee et al. 2014; O’Neill and
Wilks 2013; Stojiljkovic and Hantke 1994; Suits et al.
2005). Thus, we decided to characterize hmuQ and
hmuS of E. meliloti in order to assess their roles in
heme degradation.
HmuQ and HmuS bind one heme per molecule
and catalyze heme degradation
Recombinant E. meliloti HmuQ and HmuS were
overexpressed in E. coli as N-terminal His6-tag fusion
proteins and purified by affinity chromatography. Both
proteins migrated on sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis according to their
calculated molecular masses as his6-tag fusions,
13,924 Da for HmuQ and 41,441 Da for HmuS
(Fig. S2). Heme binding capability of 10 lM HmuQ
and 10 lM HmuS was assessed spectrophotometri-
cally (Fig. 1a, b respectively). Both proteins displayed
a Soret peak at 413 nm. When proteins were titrated
with increasing amounts of heme, the Soret peak
absorbance increased, showing an inflection point at
10 lM hemin (Fig. 1a, b, insets). The data indicate a
single site of heme binding for each one of the
proteins. Spectroscopic analyses indicate that HmuQ
has a Kd of 5.1 ± 1.2 lM and HmuS a Kd of
4.4 ± 0.7 lM.
With the aim at determining heme degradation
activity of HmuQ and HmuS, a single turnover assay
was performed in the presence of catalase. Catalase is
required to avoid the possible molecular oxygen-
mediated couple oxidation of heme in the presence of
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free H2O2 (Sigman et al. 2001). As the in vivo electron
donor of bacterial heme oxygenases is not known and,
taking into account previous works on bacterial heme
oxygenases (Frankenberg-Dinkel 2004; Puri and
O’Brian 2006; Unno et al. 2007; Zhu et al. 2000),
ascorbate or NADPH-cytochrome P450 reductase
were used as reductants in the in vitro assays. Analysis
of HmuQ-heme and HmuS-heme complexes in the
presence of ascorbic acid showed a decrease in the
Soret peak at 409 nm as a function of time as expected
for a heme-degrading enzyme. As shown in Fig. 2a, b,
HmuS-heme degradation was faster than HmuQ-heme
degradation while heme in the absence of enzymes
showed no significant spectral change during the time
of the assay (Fig. S3). HmuQ-heme and HmuS-heme
complexes were also incubated with NADPH-cy-
tochrome P450 reductase, and in these assays,
degradation of heme was monitored spectrophotomet-
rically with the addition of 10 lM increments of
NADPH. A decrease in the Soret peak at 409 nm was
also observed; nonetheless, in this condition, no
significant differences between HmuQ and HmuS
activities were detected (Fig. 2c, d). An increase in a
peak at 340 nm was observed corresponding to
absorption of NADPH, presumably because the sub-
strate became depleted and the NADPH was not
completely oxidized. Taken together, results pre-
sented here clearly show that HmuQ and HmuS
proteins catalyze heme degradation in vitro using
either ascorbate or NADPH-cytochrome P450 reduc-
tase as reductants.
Biliverdin is produced from HmuQ- and HmuS-
catalyzed heme degradation
The HmuQ and HmuS products were analyzed by
HPLC–MS. Commercialized biliverdin IX-awas used
as a standard (Fig. 3a), and a main peak with a
retention time (RT) of 6.48–7.85 was identified. A
reaction without enzymes was used as a control and
biliverdin was not detected in this reaction (Fig. 3b).
Products obtained after HmuQ-catalyzed reaction
gave one peak with the same atomic mass as biliverdin
(m/z = 583.2) (Fig. 3c) with a RT of 5.96–6.16.
Degradation products of HmuS displayed two peaks
with the same atomic mass to biliverdin (Fig. 3d).
These two peaks showed retention times of 6.44–6.64
and 6.05–6.27, demonstrating that HmuS-dependent
heme degradation yields two biliverdin isomers. These
results indicate that heme degradation products cat-
alyzed by HmuQ and HmuS are biliverdins and
suggest that the isomers produced are not biliverdin
IX-a. From the relative abundance (RA) of biliverdin
isomers obtained, we can conclude that heme degra-
dation catalyzed by HmuS produces 3.3 times more
biliverdin than HmuQ when ascorbate was used as
reductant.
In order to identify the biliverdin isomers produced
by heme degradation by HmuQ and HmuS, the
dimethyl esters of biliverdin IX-a, IX-b, IX-c and
IX-d, obtained by chemical oxidation of Fe(III)-
protoporphyrin IX dimethyl ester, were used as
standards for the HPLC analysis (Fig. S4a). The
dimethyl-esterified derivatives of the products
obtained from HmuQ and HmuS catalysis were co-
injected with each one of the four isomers. The HmuQ
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Fig. 1 Hemin binding assays. Absorption spectra of recombi-
nant HmuQ (a) and HmuS (b) proteins in the presence of
increasing concentrations of hemin are shown. The sample and
reference cuvettes were titrated with increasing hemin concen-
trations as described in the text, and the spectrum was recorded
after each addition. The sample cuvette also contained 10 lMof
either recombinant protein HmuQ or HmuS. Numbers over the
spectra indicate increasing amounts of hemin (lM). The arrow
indicates an increase in absorption with increasing amounts of
added hemin. In the insets, the absorption at 413 nm displayed
by each protein in the binding assays was plot against hemin
concentrations. Data shown in this figure are from a single
experiment representative of at least three independent assays
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heme degradation product co-eluted with biliverdin
IX-d dimethyl ester (Fig. S4b). The dimethyl-esteri-
fied derivatives of the products obtained from the
oxidation of heme by HmuS showed two peaks, one of
them eluted together with biliverdin IX-b dimethyl
ester and the other with biliverdin IX-d dimethyl ester
(Fig. S4c).Thus, these observations demonstrate that
heme is oxidized by HmuQ to produce biliverdin IX-d
while HmuS catalyzes heme oxidation with the
production of two different biliverdin isomers (bili-
verdin IX-b and biliverdin IX-d).
The expression of hmuQ and hmuS genes respond
to iron and hemin
In a previous report, Chao et al. (2004) described
hmuPSTUV to be iron regulated in a RirA-dependent
manner, which is consistent with the presence of a
putative RirA box in the promoter region reported by
Rodionov et al. (Rodionov et al. 2006). Also, the ORFs
smc01514, smc01516, smc01517 and hmuQ were
reported to have a similar RirA-dependent regulation
pattern (Chao et al. 2005). In order to evaluate the role
of hemin in the regulation of hmuQ and hmuS, we
compared by qPCR the expression of both genes in
cells grown in different conditions of iron and hemin
availability. The smc03224 gene encoding 16S rDNA
was used as a constitutive control gene. As shown in
Fig. 4, hmuQ and hmuS genes were expressed in iron
restricted medium and repressed in iron sufficient
conditions. Expression of both genes was inversely
correlated with the hemin concentration of growth
medium in presence of the free-iron chelator EDDHA.
In addition, hmuS gene expression was almost two
times higher than hmuQ gene expression in medium
with 300 lM EDDHA and 1 lM hemin.
To determine if hmuS regulation depends on RirA,
a plasmid-borne hmuS-GFP-UV promoter fusion was
introduced in the parental and in the rirA mutant
strains, and GFP activity was measured (Fig. S5a).
Repression of hmuS by iron or hemin was lost in a rirA
mutant background, demonstrating that this repression
is mediated by the RirA protein. A similar regulatory
pattern was observed for hmuQ (Fig. S5b).
Fig. 2 Spectroscopic analysis of heme degradation by HmuQ
and HmuS. Degradation of 8 lMhemin by 10 lMHmuQ (a and
c) and 10 lM HmuS (b and d) in the presence of catalase was
initiated by the addition of 10 mM ascorbic acid (a and b) or
10 lM NADPH (c and d). Spectra were recorded at different
time intervals. Numbers over the spectra indicate either time
(a and b) or NADPH micromolar concentration (c and d). Data
shown in this figure are from a single experiment representative
of at least three independent assays
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HmuQ and HmuS are important for heme iron
utilization by E. meliloti
To test the role of HmuQ and HmuS in E. meliloti
physiology, we constructed isogenic hmuQ and hmuS
mutants (Sm1021-VAQ and Sm1021-VAS, respec-
tively) and an hmuQ, hmuS double mutant (Sm1021-
VAQS). Sm1021-VAS and Sm1021-VAQS mutant
strains displayed smaller colony sizes than the parental
strain and the Sm1021-VAQ mutant strain, when
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Fig. 3 HPLC–MS analysis of the heme degradation products of
HmuQ and HmuS. Purified recombinant HmuQ and HmuS were
assayed for heme oxygenase activity. The reaction products
were extracted and analyzed byHPLC-MS using biliverdin IX-a
as standard. Chromatograms of biliverdin IX-a (a), products
from the control reaction without HmuS or HmuQ proteins
(b) and, heme degradation products of HmuQ (c) or HmuS
(d) are shown. Letter ‘‘a’’ over the peaks indicates those peaks
displaying the same atomic mass than biliverdin IX (m/
z = 583.2) and letter ‘‘b’’ indicates those peaks with the same
atomic mass than peaks present in the control reaction shown in
b
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10 lMhemin was added to the medium (Fig. 5). In the
presence of 50 lM hemin all the strains exhibited
smaller colony sizes, indicative of heme toxicity, but
the effect was more pronounced in the Sm1021-VAS
and Sm1021-VAQS mutant strains, suggesting a role
of hmuS in heme detoxification.
Taking into account that iron scavenging by the
siderophore produced by E. meliloti may interfere with
heme-dependent phenotypes, growth experiments were
also performed using the Rhizobactin 1021-deficient
mutant strain, Sm1021-H38, as a genetic background.
The rhrA mutation present in the Sm1021-H38 mutant
strain was transduced to the hmuQ, hmuS and hmuQS
backgrounds as detailed in materials and methods
section, generating mutant strains Sm1021-H38VAQ,
Sm1021-H38VAS and Sm1021-H38VAQS. Addition
of hemin in the range of 0.5–50 lM clearly improved
Sm1021-H38 growth in iron chelated medium (Fig. 6),
with maximal growth observed with 5 lM hemin. The
Sm1021-H38VAQ mutant strain, displayed a lower
growth than the Sm1021-H38 strain in the range of
1 lM to 30 lM hemin. The Sm1021-H38VAS and the
Sm1021-H38VAQSmutants presented a similar growth
defect being more pronounced at hemin concentrations
in the range of 10–50 lM.
Results obtained here suggest that HmuQ and
HmuS participate in heme utilization as an iron source
at least when heme is present in the range of
0.5–40 lM. Nonetheless, the triple mutant Sm1021-
H38VAQS was still able to grow in iron-chelated
medium supplemented with hemin suggesting the
presence of a third heme degrading enzyme or of
another mechanism involved in iron release from
heme.
Moreover, results presented in Fig. 5 together with
results shown in Fig. 6 indicate that hemin concen-
trations higher than 40 lM, impaired bacterial growth
of the parental strain (colony size on solid medium and
OD620nm in liquid medium) and that this effect is more
pronounced in the hmuS mutant. These observations
suggest a role for HmuS in heme detoxification.
Discussion
In this work, we conducted a biochemical and
physiological approach to characterize two
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Fig. 4 Effect of iron availability on the expression of hmuQ and
hmuS genes. mRNA fromwild type cells grown inM9Sminimal
media supplemented with either 300 lM EDDHA, 300 lM
EDDHA and 1 lM hemin, 300 lM EDDHA and 20 lM hemin
or 37 lMFeCl3 were analyzed by qPCR. hmuQ and hmuS genes
were assessed. The data are expressed as the relative starting
quantity (SQ) of mRNA normalized to the housekeeping gene
smc03224. The data are expressed as the mean of three
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Fig. 5 Growth assays. Cells were grown in TY broth until early
stationary phase. Appropriate dilutions were made in TY broth
and then plated in TY solid media supplemented with 150 lM
EDDHA and either 5, 10 or 50 lM hemin and incubated for
5 days. The experiments were done in triplicate with similar
results
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presumptive heme degrading enzymes in E. meliloti
1021. By in vitro assays, we demonstrate that both
HmuQ and HmuS recombinant proteins bind heme
with a 1:1 stoichiometry (Fig. 1) a common feature for
heme oxygenases, IsdG-like monooxygenases and
PhuS homologs. Moreover, HmuQ and HmuS affini-
ties for heme (5 and 4 lM, respectively) were similar
to those previously reported for other heme oxyge-
nases (Gisk et al. 2012; Skaar et al. 2004). Interest-
ingly, we found that heme is oxidized by E. meliloti
HmuS to biliverdin IX-b and biliverdin IX-d a
characteristic previously reported for HemO (formerly
PigA) a heme oxygenase of P. aeruginosa and
probably for Vibrio cholerae HutZ (Gisk et al. 2012;
Ratliff et al. 2001; Uchida et al. 2012; Wegele et al.
2004). However, E. meliloti HmuS is not homolg to
HemO or to HutZ, but has 45 % SI with the PhuS
protein of P. aeruginosa. Different functions have
been reported for P. aeruginosa PhuS: acting as a
heme-chaperone for its delivery to HemO, as a HemO
titratable regulator of heme uptake (O’Neill andWilks
2013), or as a heme degrading enzyme (Lee et al.
2014). Lee et al. (Lee et al. 2014) indicate that in vitro,
heme degradation by PhuS produces verdoheme as an
intermediate in the heme breakdown pathway by
canonical heme oxygenases. Those authors suggest
that in vivo, PhuS might act not only as a heme
trafficking protein, but also as a pre-heme oxygenase
in charge of a first step of heme breakdown,
subsequently delivering the verdoheme for further
processing by HemO. In vitro heme-degradation by E.
meliloti HmuS, in the presence of ascorbate was very
efficient being almost all the heme degraded in few
minutes (Fig. 2b). However, whether HmuS is a heme
oxygenase, and/or a heme trafficking protein in vivo,
remains to be determined.
Concerning HmuQ, its closest homologs belong to
the group of the IsdG family of monooxygenases,
displaying 59 % SI with the HmuQ from B. japon-
icum. When ascorbate was used as a reductant, heme
degradation by HmuQ was almost ten times slower
than HmuS-catalyzed reaction (Fig. 2a, b). Native
reductant for HmuQ activity is not known and perhaps
this low performance of HmuQ is due to the fact that
ascorbate might not be an appropriate reductant. An
alternative explanation could be that HmuQ heme-
degrading activity requires a chaperone involved in
either heme delivery to HmuQ or in facilitating the
dissociation of the degradation product from the
protein. The product of heme degradation catalyzed
by HmuQ is biliverdin IX-d isomer. This compound
has also been reported as the heme-degradation
product of HugZ, a novel heme oxygenase from
Helicobacter pylori, different from the IsdG family of
heme-degrading monooxygenase (Guo et al. 2008; Hu
et al. 2011). The finding that different biliverdin
isomers could be obtained as a result of heme
degradation, open the question whether these heme
metabolites have unique bacterial functions.
In order to determine the conditions required for
hmuS and hmuQ expression in vivo, we evaluated their
expression under iron sufficient, iron deprived and
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Fig. 6 Growth assays. E.
meliloti 1021-H38 mutant
strain and its derivative
mutants E. meliloti
1021-H38VAQ, E. meliloti
1021-H38VAS and E.
meliloti 1021-H38VAQS
were grown inM9S minimal
medium supplemented with
300 lM EDDHA or
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iron deprived medium supplemented with different
hemin concentrations. We found that both hmuQ and
hmuS genes are repressed by iron and also by hemin.
Previously, Rodionov et al. (Rodionov et al. 2006)
described the presence of a putative RirA box in the
promoter region of hmuPSTUV operon and Chao et al.
(Chao et al. 2005) demonstrated that hmuSTUV and
hmuQ are iron regulated in a RirA dependent manner.
Results presented here are in accordance with these
data, and additionally show that hmuS and hmuQ
expression is also repressed by heme in a RirA
dependent way.
It is considered that HOs are able to provide
nutritional iron from heme, although this physiolog-
ical role is difficult to establish because the heme
oxygenase mutants usually display a subtle phenotype.
Data presented here show that in E. meliloti, growth of
hmuS and hmuQmutants was impaired in iron-limited
medium supplemented with hemin as iron source
(Fig. 6). These data, together with the fact that hmuS
and hmuQ genes are maximally expressed under iron-
deprived conditions (Fig. 4), suggest that both HmuQ
and HmuS proteins are important for the use of heme
as iron source under iron-limiting conditions. Finally,
we consider the possibility that HmuS and/or HmuQ
might also be involved in counteract heme toxicity.
We found that hmuS mutant, but not hmuQ mutant,
was sensitive to heme concentrations higher than
50 lM (Figs. 5, 6) indicating that HmuS participate in
avoiding heme toxicity.
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